JP2015504098A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504098A5
JP2015504098A5 JP2014553507A JP2014553507A JP2015504098A5 JP 2015504098 A5 JP2015504098 A5 JP 2015504098A5 JP 2014553507 A JP2014553507 A JP 2014553507A JP 2014553507 A JP2014553507 A JP 2014553507A JP 2015504098 A5 JP2015504098 A5 JP 2015504098A5
Authority
JP
Japan
Prior art keywords
drug delivery
delivery material
composite drug
material according
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014553507A
Other languages
English (en)
Japanese (ja)
Other versions
JP6282231B2 (ja
JP2015504098A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/022466 external-priority patent/WO2013112434A1/en
Publication of JP2015504098A publication Critical patent/JP2015504098A/ja
Publication of JP2015504098A5 publication Critical patent/JP2015504098A5/ja
Application granted granted Critical
Publication of JP6282231B2 publication Critical patent/JP6282231B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014553507A 2012-01-23 2013-01-22 固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子 Expired - Fee Related JP6282231B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261589681P 2012-01-23 2012-01-23
US61/589,681 2012-01-23
PCT/US2013/022466 WO2013112434A1 (en) 2012-01-23 2013-01-22 Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation

Publications (3)

Publication Number Publication Date
JP2015504098A JP2015504098A (ja) 2015-02-05
JP2015504098A5 true JP2015504098A5 (enExample) 2016-03-10
JP6282231B2 JP6282231B2 (ja) 2018-02-21

Family

ID=47630595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014553507A Expired - Fee Related JP6282231B2 (ja) 2012-01-23 2013-01-22 固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子

Country Status (17)

Country Link
US (5) US20130189369A1 (enExample)
EP (1) EP2806853B1 (enExample)
JP (1) JP6282231B2 (enExample)
KR (5) KR20200133286A (enExample)
CN (1) CN104136006B (enExample)
AU (3) AU2013212583A1 (enExample)
BR (1) BR112014017969A8 (enExample)
CA (1) CA2861348C (enExample)
DK (1) DK2806853T3 (enExample)
ES (1) ES2821526T3 (enExample)
HU (1) HUE050904T2 (enExample)
IL (2) IL233620A0 (enExample)
MX (1) MX364864B (enExample)
NZ (1) NZ627368A (enExample)
RU (1) RU2672596C2 (enExample)
WO (1) WO2013112434A1 (enExample)
ZA (1) ZA201405091B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2672596C2 (ru) * 2012-01-23 2018-11-16 Аллерган, Инк. Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
US20170112936A1 (en) * 2014-05-23 2017-04-27 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
US20150335704A1 (en) * 2014-05-23 2015-11-26 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
CN104306330A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种盐酸美金刚缓释混悬液及其制备方法
CN116942677A (zh) 2015-09-21 2023-10-27 梯瓦制药国际有限责任公司 缓释奥氮平制剂
HK1257499A1 (zh) 2015-11-12 2019-10-25 Graybug Vision, Inc. 用於治疗的聚集性微粒
US10682340B2 (en) 2016-06-30 2020-06-16 Durect Corporation Depot formulations
US10668011B2 (en) 2016-06-30 2020-06-02 Durect Corporation Depot formulations
CA3057438A1 (en) 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons
CN111201040A (zh) 2017-05-10 2020-05-26 灰色视觉公司 用于医学疗法的缓释微粒及其悬浮液
CA3069159A1 (en) * 2017-07-11 2019-01-17 Sustained Nano Systems Llc Hypercompressed pharmaceutical formulations
CN107595765A (zh) * 2017-09-22 2018-01-19 沈阳兴齐眼药股份有限公司 一种眼用缓释药物递送系统及其制备方法
GB2586975B (en) * 2019-09-09 2024-03-06 Roemex Ltd Device and method for use with subsea pipelines
WO2022153262A1 (en) 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form
EP4308106A4 (en) * 2021-03-15 2025-02-26 Oakwood Laboratories, Llc MICROSPHERE FORMULATIONS CONTAINING NALTREXONE AND METHODS OF PREPARING AND USING THE SAME
US20240277654A1 (en) 2021-07-06 2024-08-22 Mark Hasleton Treatment of serotonin reuptake inhibitor withdrawal syndrome
CN116869914A (zh) * 2023-05-30 2023-10-13 庄秉谚 无针注射系统的投递物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
ES2258495T3 (es) * 1994-04-08 2006-09-01 Qlt Usa, Inc. Composiciones de administracion liquida de farmacos.
JP2002512597A (ja) * 1996-12-20 2002-04-23 アルザ コーポレイション 注射可能な貯留槽ゲル組成物およびこの組成物の製造方法
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
CN1314452C (zh) * 2002-04-22 2007-05-09 沈阳药科大学 具有适宜相转变温度的眼用原位凝胶制剂
CN101336887A (zh) * 2002-12-04 2009-01-07 参天制药株式会社 结膜下给药用药物组合物
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US20060182781A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Methods for treating ocular conditions with cyclic lipid contraining microparticles
US7893040B2 (en) * 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
RU2485941C2 (ru) * 2007-06-25 2013-06-27 Оцука Фармасьютикал Ко., Лтд. Микросферы, имеющие структуру ядро/оболочка
EP2482804A1 (en) * 2009-10-01 2012-08-08 Evonik Degussa Corporation Microparticle compositions and methods for treating age-related macular degeneration
CN101816627B (zh) * 2010-04-16 2012-03-07 浙江大学 一种协同治疗型多物质缓释滴眼剂及制备方法
CN102100663B (zh) * 2011-01-14 2013-04-17 华南理工大学 一种pH敏感型原位凝胶纳米缓释眼药水的制备方法
RU2672596C2 (ru) * 2012-01-23 2018-11-16 Аллерган, Инк. Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе

Similar Documents

Publication Publication Date Title
RU2014134420A (ru) Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
Ding et al. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Yoo et al. Phenomenology of the initial burst release of drugs from PLGA microparticles
Mottaghitalab et al. Silk fibroin nanoparticle as a novel drug delivery system
Chen et al. Preparation, properties and challenges of the microneedles-based insulin delivery system
Grossen et al. PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
Rattanakit et al. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms
Mao et al. Recent advances in polymeric microspheres for parenteral drug delivery–part 1
Acharya et al. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Lam et al. Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveries
Meinel et al. Silk constructs for delivery of musculoskeletal therapeutics
JP7636334B2 (ja) 治療物質の眼投与のための薬物送達組成物及びその使用法
KR20190107712A (ko) 특정 위장 부위에서의 제어 방출의 투여 형태
WO2014063111A8 (en) Drug delivery medical device
JP2014111603A5 (enExample)
WO2015001087A3 (en) Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition
MX2018001499A (es) Sistema para la entrega de polimeros liquidos para la administracion prolongada de farmacos.
WO2013039621A3 (en) Methods and systems for making microtablets for drug delivery
MX383077B (es) Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.
WO2018206749A1 (en) Ocular compositions
WO2016081616A3 (en) Transdermal patch formulations for delivery of water soluble drugs, peptides, proteins and oligosaccharides
Tamaddon et al. Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis
WO2016036823A3 (en) Self-assembling drug delivery vehicles with ionically cross-linked drugs
Park et al. Research progress on detachable microneedles for advanced applications
WO2014075203A8 (es) Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina